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Febrile  reactions  are a  group  of serological  agglutination
assays  which  originated  in the beginning  of the last  cen-
tury.  They  are  still  used in  developing  countries  because
of  their  speed  and  technically  ease of application,  as  well
as  their  low  cost.  For almost  100  years,  these  studies  were
used  for  the  diagnosis  of  diseases  caused  by  the salmonella
bacteria,  such  as  typhoid  and  paratyphoid  fever  (Widal  reac-
tion)  and  brucellosis  (Huddleston  reaction),  as  well  as  for  the
detection  of  some  diseases  caused  by  rickettsias  (Weil--Felix
reaction  in  Proteus  OX19  infections).  The  presence  of  fever
in  the  clinical  picture of  all  these  infectious  ailments  was
the  origin  of the ‘‘febrile  reactions’’  denomination  and  the
‘‘febrile  agglutinins  panel’’  concept  for  patients  with  fever
of  unknown  origin;  both  terms  are  semantically  and  clinically
inappropriate.
Nowadays  febrile  reactions  are  within  the group of  assays
considered  obsolete.  They  were  undoubtedly  of  great  use
in  the  past;  however,  for  more  than  30  years,  they  have
been  substituted  by  other  methodologies,  and are  now  a
part  of  the  history  of  medicine.  When  these assays  were
initially  implemented,  sanitary  conditions  in our  country
were  poor.  Consequently,  these  infectious  diseases  had  a
high  prevalence.  Today,  even  though  eradication  of  these
ailments  has  not  been  accomplished,  it has  been  signif-
icantly  lowered.  However,  there  are  still  endemic  zones,
mainly  for  the salmonella  and  brucella  bacterias.  In bio-
statistics,  the  lowering  of  the prevalence  of  a  disease
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in a given  population  invariably  generates  a proportional
decrease  in the  predictive  diagnostic  values  for  a  lab  assay.
This  concept  is  evidently  applicable  for  febrile  reactions  as
well.
This  is  the  reason  for  which  these  studies  have signifi-
cantly  decreased  in  their diagnostic  sensitivity,  specificity
and  predictive  values  indicators.
Additionally,  there  are two  other  more  important  factors
which  limit  the  diagnostic  usefulness  of febrile  reactions  as
laboratory  assays. The  first  one  refers  to  the error  inher-
ent in  the agglutination  analytical  method,  the second  one
to  the fact that,  in  the  majority  of  cases,  the physician
makes  an inadequate  interpretation  of the  results  of  said
studies.
Analytical method
The commercial  reactive  consists  of  a suspension  of  dead
bacteria  which  are  reacted  with  serial  dilutions  from  the
patient’s  serum.  Because  this  is  an  agglutination  assay,
‘‘human  error’’  is  present,  since  no  analytical  measurement
instruments  are  used  and  the reading  of  results  depends  on
the  visual  appreciation  of the  observer.  The  last  dilution  pre-
senting  agglutination  from  the patient’s  serum  is  the  result
of  the  antibodies  titer  of  the  report.  Technically,  a subtle
difference  between  the last  two  tubes  of  the agglutina-
tion  reaction  may  not be detected  between  two  different
observers,  thus  this variation  may  cause  the possibility  of
two  discrepant  results  of  the  same  sample,  whose  titers  may
vary  (i.e. between  1:160  and  1:320).
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Major  considerations  regarding  febrile  reactions  are:
1.  The  standardization  of  commercial  antigen  is  very  defi-
cient.  This  explains  the discrepant  results  with  the same
serum  sent  to  different  clinical  laboratories;  even  when
using  different  batches  of  the same  commercial  brand
antigen,  there  may  be  different  results  in antibody
titling.
Lack  of  appropriate  commercial  antigen  standardiza-
tion  also  generates  a lack  of  proper  internal  quality
control  in clinical  laboratories,  which  do not  have trust-
worthy  accuracy  and  reproducibility  parameters  for
these  assays.  According  to the  above,  within  the  exter-
nal  quality  controls  of  serum  sample  exchange  between
different  laboratories,  there  is  an evident  lack  of  con-
cordance  in the results.
2.  Another  technical  problem  that  may  occur,  specifically  in
some  patients  with  brucellosis,  is  false  negatives,  caused
by  the  zone  phenomenon.  This  eventuality  is  not exclu-
sive  to  febrile  reactions,  since  it may  occur  in every
type  of  agglutination  or  precipitation  reaction.  This  is  a
result  of  the  lack  of  equivalencies  between  the amounts
of  commercial  antigen  and  the antibody  present  in the
patient’s  serum.  This  is  a  prozone  phenomenon,  or  anti-
body  excess.  In order  to  identify  this possible  eventuality,
serial  dilutions  of  the patient’s serum  in the  presence  of
the  same  amount  of commercial  bacterial  antigen  will
have  to be performed.
Considerations of the clinical interpretation of
febrile reactions
1.  The  main  problem  of  febrile  reactions  is  that  when
interpreting  results,  it has  not  been possible  to  have
a  uniformed  and  standardized  criteria  of which  anti-
body  titer  is  to  be  considered  a significant  cut-off  point
which  definitely  establishes  the diagnostic  criteria  of  the
disease.  This  has  led  some doctors  to  prescribe  an  antimi-
crobial  therapy  without  justification,  for  the mere  reason
of  presenting  reactivity  in any  of  the  assays.  The  latter
occurs  even  in asymptomatic  patients.
2.  An  antibody  titer  by  itself  cannot  be  associated  with  a
definite  diagnosis.  In the  endemic  areas  of the  disease,
a  significant  interpretation  of the  antibody  titer  results
is  difficult.
3.  Febrile  reactions  may  show  positive  results  in a  healthy
population,  and  antibodies’  titration  values  may  also
present  significant  variations  with  age.  This  can  be
explained  by  many  different  concepts,  including  analyt-
ical  errors,  immunological  memory  in  patients  who  had
the  disease,  anamnestic  immune  responses,  vaccinated
individuals,  or  by  the  presence  of  unspecified  crossed
reactions  with  types  of different  bacteria  which have
been  described  in Widal  reactions  with  enterobacteria,
in Huddleson  with  tularemia,  cholera  and certain types
of  yersinia  enterocolitica,  as  well  as  the  Weil  Felix  reac-
tion  in  patients  with  previous  urinary  infections,  or  who
present  leptospirosis  or  Lyme  disease.
4.  There  is also  the  possibility  of false negative  reactions
in patients  who  are using  antibiotics  or  who  are under
steroid  treatment  or  other  types  of  immunosuppressants.
On  the other  hand,  in patients  with  brucellosis,  Hud-
dleson’s  reaction  may  result  in a  negative  due  to  the
presence  of  the  prozone  effect.  This  is  just a techni-
cal  problem  caused  by  the inhibition  of  the agglutination
reaction  due  to  an  excess  of  antibodies  in  the patient’s
serum. It  is  clear  that  like  in  any  other  laboratory  assay,
all  results  must  be interpreted  according  to  the patient’s
symptomatology  and  taking  into  account  the  epidemio-
logical  factors  of  these  diseases.
5.  Antibody  detection  in  febrile  reactions  occurs  at  a  late
stage  in the  evolution  of  the disease.  This  occurs  between
the second  and fourth  week  of the clinical  picture  onset.
It  is  not  possible  to  identify  the type of  immunoglobulin  in
the  results;  it  may  be IgM,  IgG or  IgA.  Once  formed,  the
antibodies  may  persist  after the  healing  of the  disease
for  months,  and  even  years.
What  can  be  rescued from  febrile reactions?
We are now  able  to  say that  out  of the  febrile  reactions
panel,  the Huddleson  traditional  assay,  despite  some  incon-
veniences  mentioned  above,  is  the most useful.  Brucellosis
is  a  worldwide  zoonotic  disease  and  its  main  contamination
source  is  the  consumption  of non-pasteurized  dairy  prod-
ucts.  Brucella  melitensis  is  the  main  agent  linked  to  the
infection  of  human  beings.  It is  a  major  healthcare  issue  in
the  Mediterranean  Basin,  Asia  (specifically  the Middle  East)
and  Africa.  Its  incidence  is  unknown.  However,  between  1
and  200 cases per  100,000  habitants  have  been  reported. In
Latin  America,  and in our  country,  there  are well-delimited
endemic  zones.  Culture  and isolation  of the responsible
agent  in blood  and  bone  marrow  are slow  (from  7 to  21
days),  and  it can  sometimes  takes  up  to  35  days. Despite
these  difficulties,  bone  marrow  culture  specifically  remains
the  gold  standard.  Within  the clinical  laboratory,  Brucella
is  highly  infectious  and requires  a  biosafety  level 3  facil-
ity.  Thus,  serology  in the early  stages  of  the  disease  is  of
great  importance  in  diagnosis.  The  traditional  agglutination
assay  developed  by  Huddleson  has  been  modified,  standard-
izing  the commercial  antigen.  Nowadays,  a  strain  of  the
same  biotype  1  bacteria  is  used  (strain  99s or  strain  119-
3),  acidified  and dyed  with  rose bengal  to  make  the  antigen
more  visible.  It is  the same  plaque  agglutination  assay,  yet
consistently  more  specific  in the  detection  of antibodies
against Brucella  spp., while  it does  not  discriminate  the type
of  immunoglobulin  and  it is  considered  a good screening
assay.  It is  currently  used  in blood  banks  in  our  country
in  the prevention  of  brucellosis  transmission  through  blood
transfusion.
Since  1970, and  with  the advent  of  new  technolo-
gies  like  immunoassays,  these  assays  were substituted
by  the  specific  detection  of  IgG  or  IgM  immunoglobulins
against  their  respective  infectious  agents.  New  tech-
niques,  such  as  the  immunoenzymatic  assay  or  the  ELISA
(Enzyme-Linked  ImmunoSorbent  Assay)  and  the chemi-
luminescence,  have  proven  to  have  greater  diagnostic
sensitivity  and specificity,  improving  analytic  reproducibil-
ity  and  accuracy  as  well.  Thus,  nowadays  it is  possible
to  identify,  in an  earlier  manner  and  more  specifically,
the  type of  antibody  produced  by  the organism  in the
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immune  response  generated  by  bacteria  and  rickettsias,
which  participate  as  etiological  agents  of  the  diseases
which  in  the past  were  diagnosed  through  febrile  reac-
tions.
Molecular  biology  plays,  without  a doubt,  a major  role  in
the  diagnosis  of  these  groups  of infectious  ailments,  as  well
as  in  many  others.  The  challenge  is  the  high  cost  of the  new
technology,  which  is  currently  impeding its  use  on  a  more
routine  basis.
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